Trials / Withdrawn
WithdrawnNCT01640847
MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone Metastases
Phase II Trial of Phillips MRI-Guided High Intensity Focused Ultrasound (Sonalleve) and Lyso-thermosensitive Liposomal Doxorubicin (ThermoDox) for Palliation of Painful Bone Metastases
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Imunon · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate treatment with High Intensity Focused Ultrasound (HIFU)in combination with ThermoDox (liposomal doxorubicin) is safe and effective in reducing pain for patients with painful bone metastases.
Conditions
- Painful Bone Metastases
- Breast Carcinoma
- Non-small Cell Lung Cancer
- Small Cell Lung Cancer
- Adenocarcinoma
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | High Intensity Focused Ultrasound (HIFU) in combination with ThermoDox |
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2013-06-01
- Completion
- 2013-07-01
- First posted
- 2012-07-16
- Last updated
- 2017-02-07
Source: ClinicalTrials.gov record NCT01640847. Inclusion in this directory is not an endorsement.